trialled < trials < triazole

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 45.
[0-20] [0 - 20][0 - 45][20-40]

Ident.	Authors (with country if any)	Title
000003 (2020)	Charlotte Girard-Guyonvarc'H ; Michele Iudici	[Targeted therapies for connective tissue diseases and vasculitis].
000012 (2020)	Seoyoung C. Kim [États-Unis] ; Sebastian Schneeweiss [États-Unis]	When Randomized Clinical Trials and Real-World Evidence Say the Same: Tocilizumab and Its Cardiovascular Safety.
000020 (2020)	Jared Radbel [États-Unis] ; Navaneeth Narayanan [États-Unis] ; Pinki J. Bhatt [États-Unis]	Use of tocilizumab for COVID-19 infection-induced cytokine release syndrome: A cautionary case report.
000032 (2020)	Marc Feldmann [Royaume-Uni] ; Ravinder N. Maini [Royaume-Uni] ; James N. Woody [États-Unis] ; Stephen T. Holgate [Royaume-Uni] ; Gregory Winter [Royaume-Uni] ; Matthew Rowland [Royaume-Uni] ; Duncan Richards [Royaume-Uni] ; Tracy Hussell [Royaume-Uni]	Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
000042 (2020)	Prakhar Vijayvargiya [États-Unis] ; Zerelda Esquer Garrigos [États-Unis] ; Natalia E. Castillo Almeida [États-Unis] ; Pooja R. Gurram [États-Unis] ; Ryan W. Stevens [États-Unis] ; Raymund R. Razonable [États-Unis]	Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)
000079 (2020)	Caterina Vacchi [Italie] ; Marco Sebastiani [Italie] ; Giulia Cassone [Italie] ; Stefania Cerri [Italie] ; Giovanni Della Casa [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]	Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
000122 (2020)	Timothy M. Smith ; Anuj Tharakan ; Rebecca K. Martin	Targeting ADAM10 in Cancer and Autoimmunity
000156 (2020)	Shuichiro Nakabo [Japon] ; Yuko Tsuji [Japon] ; Maiko Inagaki [Japon] ; Hideaki Tsuji [Japon] ; Toshiki Nakajima [Japon] ; Kosaku Murakami [Japon] ; Chikashi Terao [Japon] ; Motomu Hashimoto [Japon] ; Moritoshi Furu [Japon] ; Masao Tanaka [Japon] ; Hiromu Ito [Japon] ; Takao Fujii [Japon] ; Tsuneyo Mimori [Japon] ; Yasutomo Fujii [Japon]	Severe joint deformity and Patient Global Assessment of Disease are associated with discrepancies between sonographic and clinical remission: A cross-sectional study of rheumatoid arthritis patients.
000168 (2020)	Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Sakae Tanaka [Japon] ; Atsushi Kawakami [Japon] ; Yeong-Wook Song [Corée du Sud] ; Yi-Hsing Chen [Taïwan] ; Mitsuhiro Rokuda [Japon] ; Hiroyuki Izutsu [Japon] ; Satoshi Ushijima [Japon] ; Yuichiro Kaneko [Japon] ; Yoshihiro Nakashima [Japon] ; Teruaki Shiomi [Japon] ; Emi Yamada [Japon]	Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan
000187 (2020)	Durga Prasanna Misra [Inde] ; Vikas Agarwal [Inde] ; Armen Yuri Gasparyan ; Olena Zimba [Ukraine]	Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
000193 (2020)	Ka-Tim Choy [République populaire de Chine] ; Alvina Yin-Lam Wong [République populaire de Chine] ; Prathanporn Kaewpreedee [République populaire de Chine] ; Sin Fun Sia [République populaire de Chine] ; Dongdong Chen [République populaire de Chine] ; Kenrie Pui Yan Hui [République populaire de Chine] ; Daniel Ka Wing Chu [République populaire de Chine] ; Michael Chi Wai Chan [République populaire de Chine] ; Peter Pak-Hang Cheung [République populaire de Chine] ; Xuhui Huang [République populaire de Chine] ; Malik Peiris [République populaire de Chine] ; Hui-Ling Yen [République populaire de Chine]	Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
000199 (2020)	Tarek Mohamed Abd El-Aziz [États-Unis, Égypte] ; James D. Stockand [États-Unis]	Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
000207 (2020)	Shengyu Zhang ; Lei Li ; Aizong Shen ; Yongwu Chen ; Zhigang Qi	Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
000210 (2020)	Thomas Koudstaal ; Karin A. Boomars ; Mirjam Kool	Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective
000214 (2020)	Alyson W. Wong [Canada] ; Christopher J. Ryerson [Canada] ; Sabina A. Guler [Suisse]	Progression of fibrosing interstitial lung disease
000223 (2020)	Chih-Chia Lu [République populaire de Chine] ; Mei-Yu Chen [République populaire de Chine] ; Yuh-Lih Chang	Potential therapeutic agents against COVID-19: What we know so far
000231 (2020)	Katie Bechman [Royaume-Uni] ; Mark Yates [Royaume-Uni] ; Sam Norton [Royaume-Uni] ; Andrew P. Cope [Royaume-Uni] ; James B. Galloway [Royaume-Uni]	Placebo Response in Rheumatoid Arthritis Clinical Trials.
000233 (2020)	Giulia Cassone [Italie] ; Marco Sebastiani [Italie] ; Caterina Vacchi [Italie] ; Stefania Cerri [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]	Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming?
000249 (2020)	Mark P. Lythgoe [Royaume-Uni] ; Paul Middleton [Royaume-Uni]	Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
000257 (2020)	Stefanie Glaubitz ; Rachel Zeng ; Jens Schmidt	New insights into the treatment of myositis
000258 (2020)	Peter N. Taylor [Royaume-Uni] ; Lei Zhang [Royaume-Uni] ; Richard W J. Lee [Royaume-Uni] ; Ilaria Muller [Royaume-Uni] ; Daniel G. Ezra [Royaume-Uni] ; Colin M. Dayan [Royaume-Uni] ; George J. Kahaly [Allemagne] ; Marian Ludgate [Royaume-Uni]	New insights into the pathogenesis and nonsurgical management of Graves orbitopathy.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "trials" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "trials" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    trials
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021